Skip to main content

Table 2 Clinical characteristics of HIV/AIDS patients receiving ART in the clinic of NACP at Al-Jomhori Educational Hospital in Sana’a, Yemen (2019–2020)

From: Intestinal microsporidiosis among HIV/AIDS patients receiving antiretroviral therapy in Sana’a city, Yemen: first report on prevalence and predictors

Characteristics

n

(%)

CD4 cell count (/µl)a

 < 200

90

(22.7)

 ≥ 200

306

(77.3)

 Median ± IQR: 355 ± 288

  

Diarrhea

  

 Yes

52

(12.9)

 No

350

(87.1)

Nausea

  

 Yes

91

(22.6)

 No

311

(77.4)

Vomiting

 Yes

38

(9.5)

 No

364

(90.5)

Abdominal pain

  

 Yes

132

(32.8)

 No

270

(67.2)

  1. The total number of patients included in the study was 402; asix missing cases
  2. HIV human immunodeficiency virus, AIDS acquired immunodeficiency syndrome, ART antiretroviral therapy, NACP National AIDS Control Program, CD4 cluster of differentiation 4, IQR interquartile range